Literature DB >> 22855580

The relationship between homologous recombination repair and the sensitivity of human epidermis to the size of daily doses over a 5-week course of breast radiotherapy.

Navita Somaiah1, John Yarnold, Frances Daley, Ann Pearson, Lone Gothard, Kai Rothkamm, Thomas Helleday.   

Abstract

PURPOSE: A molecular understanding of tissue sensitivity to radiotherapy fraction size is missing. Here, we test the hypothesis that sensitivity to fraction size is influenced by the DNA repair system activated in response to DNA double-strand breaks (DSB). Human epidermis was used as a model in which proliferation and DNA repair were correlated over 5 weeks of radiotherapy. EXPERIMENTAL
DESIGN: Radiotherapy (25 fractions of 2 Gy) was prescribed to the breast in 30 women with early breast cancer. Breast skin biopsies were collected 2 hours after the 1st and 25th fractions. Samples of contralateral breast skin served as controls. Sections were coimmunostained for Ki67, cyclin A, p21, RAD51, 53BP1, and β1-integrin.
RESULTS: After 5 weeks of radiotherapy, the mean basal Ki67 density increased from 5.72 to 15.46 cells per millimeter of basement membrane (P = 0.002), of which the majority were in S/G2 phase, as judged by cyclin A staining (P < 0.0003). The p21 index rose from 2.8% to 87.4% (P < 0.0001) after 25 fractions, indicating cell cycle arrest. By week 5, there was a 4-fold increase (P = 0.0003) in the proportion of Ki67-positive cells showing RAD51 foci, suggesting increasing activation of homologous recombination.
CONCLUSIONS: Cell cycle arrest in S/G2 phase in the basal epidermis after a 5-week course of radiotherapy is associated with greater use of homologous recombination for repairing DSB. The high fidelity of homologous recombination, which is independent of DNA damage levels, may explain the low-fractionation sensitivity of tissues with high-proliferative indices, including self-renewing normal tissues and many cancers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855580     DOI: 10.1158/1078-0432.CCR-10-3297

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  9 in total

1.  Rosiglitazone enhances radiosensitivity by inhibiting repair of DNA damage in cervical cancer cells.

Authors:  Zhengzhe An; Jae-Ran Yu; Woo-Yoon Park
Journal:  Radiat Environ Biophys       Date:  2017-02-09       Impact factor: 1.925

Review 2.  Deoxyribonucleic acid damage-associated biomarkers of ionising radiation: current status and future relevance for radiology and radiotherapy.

Authors:  G Manning; K Rothkamm
Journal:  Br J Radiol       Date:  2013-05-09       Impact factor: 3.039

3.  Visualization of complex DNA double-strand breaks in a tumor treated with carbon ion radiotherapy.

Authors:  Takahiro Oike; Atsuko Niimi; Noriyuki Okonogi; Kazutoshi Murata; Akihiko Matsumura; Shin-Ei Noda; Daijiro Kobayashi; Mototaro Iwanaga; Keisuke Tsuchida; Tatsuaki Kanai; Tatsuya Ohno; Atsushi Shibata; Takashi Nakano
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

4.  Dynamic In Vivo Profiling of DNA Damage and Repair after Radiotherapy Using Canine Patients as a Model.

Authors:  Nadine Schulz; Hassan Chaachouay; Katarzyna J Nytko; Mathias S Weyland; Malgorzata Roos; Rudolf M Füchslin; Franco Guscetti; Stephan Scheidegger; Carla Rohrer Bley
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

5.  Simulation analysis for tumor radiotherapy based on three-component mathematical models.

Authors:  Wen-Song Hong; Gang-Qing Zhang
Journal:  J Appl Clin Med Phys       Date:  2019-03       Impact factor: 2.102

6.  TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells.

Authors:  Selvakumar Anbalagan; Cecilia Ström; Jessica A Downs; Penny A Jeggo; David McBay; Anna Wilkins; Kai Rothkamm; Kevin J Harrington; John R Yarnold; Navita Somaiah
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

7.  DNA damage response and DNA repair - dog as a model?

Authors:  Nicole Grosse; Barbara van Loon; Carla Rohrer Bley
Journal:  BMC Cancer       Date:  2014-03-19       Impact factor: 4.430

Review 8.  Genomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate Cancer.

Authors:  Anna Wilkins; David Dearnaley; Navita Somaiah
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

9.  Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer.

Authors:  Anna C Wilkins; Barry Gusterson; Zsolt Szijgyarto; Joanne Haviland; Clare Griffin; Christine Stuttle; Frances Daley; Catherine M Corbishley; David P Dearnaley; Emma Hall; Navita Somaiah
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-02-03       Impact factor: 7.038

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.